Skip to main content
. Author manuscript; available in PMC: 2015 Apr 29.
Published in final edited form as: Sci Transl Med. 2014 Apr 16;6(232):232ra50. doi: 10.1126/scitranslmed.3008264

Table 1.

Subjects for serum determination of FnEDA. The serum creatinine level was 0.74 ± 0.2mg/dl (mean±SD), and only 3 of 48 patients had serum creatinine level >1.0 mg/dl; none had levels >1.35 mg/dl. Controls were healthy women (median age, 49 years; range, 34 to 62 years). dcSSc diffuse cutaneous SSc DLco, diffusing capacity for carbon monoxide; F, female; FVC, forced vital capacity; lcSSc limited cutaneous SSc; M, male; mRSS, modified Rodnan skin score (1 to 51).

Study code Age (years) Sex Disease subtype Disease stage (early/late)* mRSS FVC (% predicted) DLco (% predicted)
SScReg_1010_2 57 F dcSSc Late 15 99 74
SScReg_1024_2 54 F dcSSc Late 22 67 86
SScReg_1073_2 61 F dcSSc Late 9 73 60
SScReg_1080_2 55 F dcSSc Early 19 81 82
SScReg_1084_2 57 M dcSSc Late 10 80 72
SScReg_1100_2 39 F dcSSc Early 14 61 43
SScReg_1107_2 48 M dcSSc Early 25 96 94
SScReg_1121_2 47 F dcSSc Late 26 71 75
SScReg_1046_2 37 F dcSSc Late 21 73 62
SScReg_1154_2 56 F dcSSc Late 13 87 85
SScReg_1156_2 48 F dcSSc Early 23 77
SScReg_1141_2 52 F dcSSc Early 16 75 53
SScReg_1182_2 50 F dcSSc Late 9 77 61
SScReg_1213_3 30 F dcSSc Late 10 81 82
SScReg_1266_3 66 F dcSSc Early 14 64 72
SScReg_1068_2 49 F dcSSc Late 27 83 88
SScReg_1097_2 64 F dcSSc Early 9 66 65
SScReg_1103_2 54 F dcSSc Late 13 70 70
SScReg_1043_2 61 F dcSSc Late 7 78 72
SScReg_1095_2 42 F dcSSc Late 11 83 60
SScReg_1102_3 29 F dcSSc Late 20 72 56
SScReg_1048_3 39 M dcSSc Late 12 89 81
SScReg_1117_3 45 F dcSSc Late 23 94 65
SScReg_1221_3 57 F dcSSc Early 12 95 81
SScReg_1248_2 63 F dcSSc Late 36 97 64
SScReg_1258_1 57 F dcSSc Late 2 90 55
SScReg_1271_2 50 F dcSSc Late 25 56 43
SScReg_1279_3 59 F dcSSc Late 12 75 60
SScReg_1313_3 62 F dcSSc Late 49 86 44
SScReg_1332_2 47 F dcSSc Late 26 50 21
SScReg_1354_3 42 F dcSSc Early 29 100 76
SScReg_1370_2 45 F dcSSc Early 23 100 71
SScReg_1380_2 56 F dcSSc Early 7 91 42
SScReg_1386_2 63 F dcSSc Early 22 102 53
SScReg_1366_2 55 F dcSSc Early 23 76 75
SScReg_1392_3 47 F dcSSc Early 19 67 76
SScReg_1397_3 52 F dcSSc Late 22 105 64
SScReg_1402_3 48 F dcSSc Early 7 72 21
SScReg_1405_3 52 F dcSSc Early 13 77 58
SScReg_1410_3 56 F dcSSc Early 17 81 77
SScReg_1006_3 47 F dcSSc Late 3 101 99
SScReg_1412_3 65 F dcSSc Late 6 100 96
SScReg_1119_3 56 M dcSSc Late 38 41 26
SScReg_1198_3 59 F dcSSc Late 5 76 53
SScReg_1393_3 41 F dcSSc Late 14 40 42
SScReg_1320_3 31 F dcSSc Late 10 44 60
SScReg_1070_3 62 F dcSSc Late 13 25 15
SScReg_1426_2 28 F dcSSc Late 18 89 82
*

Early, <2 years from first non-Raynaud disease manifestation; late, >2 years from first non-Raynaud manifestation.